Abstracts

DIMENSIONALITY REDUCTION FOR STEPWISE ANALYSIS OF IMMUNE RESPONSE DYNAMICS IN COVID19

COVID-19 is highly heterogeneous in clinical severity and outcome. Considerable advances have uncovered biomolecular traits associated with fatal outcome. However, novel analytical tools are needed to rapidly and accurately delineate patient subgroups with various immunovirological profiles, analyze diverging disease trajectories and prioritize in-depth molecular studies. To find how immunovirological features are interrelated, we profiled 12…

SARS-CoV-2 VACCINE IMMUNOGENICITY IN PLWH IN THE NETHERLANDS

Vaccines can be less immunogenic in people living with HIV (PLWH). So far, the immune response after SARS-CoV-2 vaccination of PLWH is not well-established. A prospective cohort study in 22 HIV treatment centres in the Netherlands examined the immunogenicity of SARS-CoV-2 vaccines in PLWH. Included were adult PLWH without prior COVID-19 infection, invited by the…

HUMORAL RESPONSE TO SARS-CoV-2 mRNA VACCINE IN HEART TRANSPLANT RECIPIENTS

Recent studies reported poor to moderate humoral response after two vaccine doses in heart transplant recipients (HTR). Currently, French healthcare authorities recommend 2 and 3 vaccine injections for transplant recipients with and without prior SARS-CoV-2 infection, respectively. This study aimed to evaluate level and durability of humoral immunity with this vaccination strategy. This single-center cohort…